Co-Authors
This is a "connection" page, showing publications co-authored by Thomas Marjot and A Barritt.
Connection Strength
1.708
-
COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021 05; 18(5):348-364.
Score: 0.233
-
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. J Hepatol. 2021 07; 75(1):226-228.
Score: 0.232
-
SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol. 2021 06; 74(6):1335-1343.
Score: 0.232
-
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021 03; 6(3):156-158.
Score: 0.231
-
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021 03; 74(3):567-577.
Score: 0.227
-
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry. J Hepatol. 2020 09; 73(3):705-708.
Score: 0.221
-
Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol. 2020 07; 5(7):643-644.
Score: 0.220
-
COVID-19 and liver transplantation: the jury is still out - Authors' reply. Lancet Gastroenterol Hepatol. 2021 01; 6(1):11.
Score: 0.057
-
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol. 2020 11; 5(11):1008-1016.
Score: 0.056